Cornelis (Cox) Pieter Terhorst

Affiliations: 
Immunology Harvard Medical School, Boston, MA, United States 
Website:
http://www.hms.harvard.edu/dms/immunology/fac/Terhorst.php
Google:
"Cornelis Pieter Terhorst"
Bio:

http://www.bidmc.org/~/media/Files/Centers%20and%20Departments/Medicine/Annual%20Report%20PDFs/2015InteractiveReport_Hi.pdf Cox Terhorst, PhD, Chief of the Division of Immunology, received his doctorate in Molecular Biology from the University of Leiden in the Netherlands. His work there with the late Wim Möller, PhD, was on the ribosomal proteins L7/L12, which are docking sites for GTPase factors involved in protein synthesis.
Terhorst then did his post-doctoral work on HLA proteins at Harvard University under the mentorship of Jack Strominger, MD.

DOI: 10.1016/0014-5793(70)80261-7

Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Wilhelmus (Wim) Johannes Hubertus Maria Möller grad student 1973 Leiden
 (Structural studies on a 50S ribosomal protein involved in the hydrolysis of guanosine 5'-triphosphate.)
Jack L. Strominger post-doc Harvard
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bertolini TB, Biswas M, Terhorst C, et al. (2020) Role of orally induced regulatory T cells in immunotherapy and tolerance. Cellular Immunology. 359: 104251
Tsokos GC, Terhorst C. (2020) T Lymphocytes Cash Their Value in Clinical Medicine. Trends in Molecular Medicine. 26: 800-802
Kumar SRP, Wang X, Avuthu N, et al. (2020) Role of Small Intestine and Gut Microbiome in Plant-Based Oral Tolerance for Hemophilia. Frontiers in Immunology. 11: 844
Shirley JL, de Jong YP, Terhorst C, et al. (2020) Immune Responses to Viral Gene Therapy Vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy
Shirley JL, Keeler GD, Sherman A, et al. (2019) Type I IFN Sensing by cDCs and CD4 T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8 T Cells. Molecular Therapy : the Journal of the American Society of Gene Therapy
Yigit B, Wang N, Ten Hacken E, et al. (2019) SLAMF6 as a regulator of exhausted CD8+ T cells in cancer. Cancer Immunology Research
Butterfield JSS, Biswas M, Shirley JL, et al. (2019) TLR9-activating CpG-B ODN but not TLR7 Agonists Trigger Antibody Formation to Factor IX in Muscle Gene Transfer. Human Gene Therapy Methods
Wang N, Yigit B, van der Poel CE, et al. (2019) The Checkpoint Regulator SLAMF3 Preferentially Prevents Expansion of Auto-Reactive B Cells Generated by Graft-vs.-Host Disease. Frontiers in Immunology. 10: 831
Herzog RW, Kuteyeva V, Saboungi R, et al. (2019) Reprogrammed CD4 T Cells That Express FoxP3 Control Inhibitory Antibody Formation in Hemophilia A Mice. Frontiers in Immunology. 10: 274
Chaudhary A, Kamischke C, Leite M, et al. (2018) β-Barrel outer membrane proteins suppress mTORC2 activation and induce autophagic responses. Science Signaling. 11
See more...